Abstract

Narrow complex tachycardia usually refers to an abnormality of cardiac rhythm involving the tissues of the sinus node, atrial tissue, the atrioventricular node or an accessory atrioventricular communication. Although atrial fibrillation is the most common supraventricular arrhythmia, the term “supraventricular tachycardia” conventionally refers to the group of rhythm disturbances encompassing sinus tachycardia (appropriate and inappropriate), atrial tachycardia, atrial flutter, atrioventricular nodal reciprocating tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT) including the Wolff Parkinson White syndrome (WPW). Atrial fibrillation is beyond the scope of this article which focuses on the diagnosis and acute management of the patient presenting with one of these common causes of a regular, narrow complex tachycardia.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. O’Neill MD & Davies DW. Cardiac arrhythmias part II: Broad Complex Tachycardia. CPD Journal Acute Medicine 2005; 4: 3-9
2. Goudevenos JA, Katsouras CS, Graekas G, et al; Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course. Heart 2000; 83: 29-34
3. Pappone C, Manguso F, Santinelli R, Vicedomini G, et al; Radiofrequency Ablation in Children with Asymptomatic WolffParkinson-White Syndrome. N Engl J Med 2004; 351: 1197-1205
4. Goyal R, Zivin A, Souza J, Shaikh SA, et al; Comparison of the ages of tachycardia onset in patients with atrioventricular nodal re-entrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J 1996;132: 765-767
5. Waldo AL. Atrial Flutter: Mechanisms, Clinical Features and Management, Zipes, DP & Jalife J editors Cardiac Electrophysiology – From Cell to Bedside. Third Edition. Philadelphia 2000, W.B. Saunders Company, Chapter 54; page 468
6. Rodriquez LM, de Chillou C, Schlapfer J, et al; Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol 1992; 70: 1213-1215
7. Miles WM & Zipes DP. Atrioventricular Reentry and Variants: Mechanisms, Clinical Features, and Management, Zipes, DP & Jalife J editors Cardiac Electrophysiology – From Cell to Bedside. Third Edition. Philadelphia 2000, W.B. Saunders Company, Chapter 57; page 488
8. Perloff JK. Physical examination of the heart and circulation. Third edition, Philadelphia 2000, W.B. Saunders Company.
9. Chow LT, Chow SS, Anderson RH, Gosling JA. Autonomic innervation of the human cardiac conduction system: changes from infancy to senility – an immunohistochemical and histochemical analysis. Anat Rec 2001; 264: 169-82
10. Shryock JC, Boykin MT, Hill JA & Belardinelli L. A new method of sampling blood for measurement of plasma adenosine. Am J Physiol 1990; 258: H1232-H1239
11. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, et al; ACC/AHA/ESC Guidelines for the Management of Patients with Supraventricular Arrrhythmias – Executive Summary. A report on the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to develop guidelines for the management of patients with supraventricular arrhythmias). European Heart Journal 2003; 24:1857-97
12. Terry P & Lumsden G. Using intravenous adenosine in asthmatics. Emerg Med J 2001; 18: 61
13. Glatter KA, Cheng J, Dorostkar P, et al; Electrophysiological effects of adenosine in patients with supraventricular tachycardia. Circulation Tan HL, Spekhorst HHM, Peters RJG & Wilde AAM. Adenosineinduced ventricular arrhythmias in the emergency room. PACE 2001; 24:450-455
14. Schilling RJ. Which patient should be referred to an electrophysiologist: supraventricular tachycardia. Heart 2002; 87: 299-304
15. Seidl K, Hauer B, Schwick NG, et al;. Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 1998; 82: 580-583